JP Patent

JP4369120B2 — 精製された造血性鉄−サッカリド錯体の生成方法およびそれによって生成した生成物

Assigned to クロマシューティカル・アドヴァンスト・テクノロジーズ，インコーポレイテッド · Expires 2009-11-18 · 16y expired

What this patent protects

Patent listed against Injectafer.

Drugs covered by this patent

Patent Metadata

Patent number
JP4369120B2
Jurisdiction
JP
Classification
—
Expires
2009-11-18
Drug substance claim
No
Drug product claim
No
Assignee
クロマシューティカル・アドヴァンスト・テクノロジーズ，インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.